Covered recipient · General Payments record
RAMIN BERENJI
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$8,231.66
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $2,017.86 | 5 |
| Food and Beverage | $647.55 | 11 |
| Education | $2.38 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Behring | $2,132.26 | 8 |
| Acerta Pharma LLC | $346.71 | 4 |
| NXSTAGE MEDICAL, INC. | $78.34 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $71.48 | 1 |
| Aurinia Pharma U.S., Inc. | $36.62 | 1 |
| Retrophin, Inc. | $2.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $97.70 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105390515 | CMS |
| AstraZeneca Pharmaceuticals LP | $93.65 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105611301 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.51 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105324127 | CMS |
| AstraZeneca Pharmaceuticals LP | $35.85 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105777306 | CMS |
| Aurinia Pharma U.S., Inc. | $36.62 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150676545 | CMS |
| Boston Scientific Corporation | $71.48 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092713932 | CMS |
| CSL Behring | $1,137.07 | 10/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134611865 | CMS |
| CSL Behring | $151.28 | 10/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134611867 | CMS |
| CSL Behring | $50.05 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134611869 | CMS |
| CSL Behring | $443.00 | 10/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134611893 | CMS |
| CSL Behring | $151.28 | 10/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134611895 | CMS |
| CSL Behring | $28.60 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134611897 | CMS |
| CSL Behring | $35.75 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134611899 | CMS |
| CSL Behring | $135.23 | 11/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134611849 | CMS |
| NXSTAGE MEDICAL, INC. | $44.85 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154283241 | CMS |
| NXSTAGE MEDICAL, INC. | $33.49 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154283239 | CMS |
| Travere Therapeutics, Inc. | $2.38 | 05/08/2024 | Education | Undisputed | 01/23/2026 | 1149910673 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.